Literature DB >> 6767527

Plasma 1,25-dihydroxyvitamin D concentrations in cords, newborns, infants, and children.

Y Seino, T Shimotsuji, K Yamaoka, M Ishida, T Ishii, S Matsuda, C Ikehara, H Yabuuchi, S Dokoh.   

Abstract

Plasma 1,25-dihydroxyvitamin D [1,25-(OH)2-D] was measured in cord serum, newborns, infants, and children. The mean for the values obtained from the six cords was significantly higher than the mean for the older children (6-15 years). The mean for the six newborns (0-1 week) was significantly higher than that for the older children. The mean for the nine infants (1 week-6 months) and the 14 younger children (6 months-6 years) was significantly higher than that for older children. The present study suggests that the perinatal period is associated with a marked increase in 1,25-(OH)2-D.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767527     DOI: 10.1007/bf02408599

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  8 in total

1.  Serum electrolytes in pregnancy, parturition, and puerperium.

Authors:  R L NEWMAN
Journal:  Obstet Gynecol       Date:  1957-07       Impact factor: 7.661

2.  1,25-Dihydroxyvitamin D3: mode of action in intestine and parathyroid glands, assay in humans and isolation of its glycoside from Solanum malacoxylon.

Authors:  M R Haussler; M R Hughes; T A McCain; J E Zerwekh; P F Brumbaugh; W Jubiz; R H Wasserman
Journal:  Calcif Tissue Res       Date:  1977-05

3.  Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.

Authors:  C R Scriver; T M Reade; H F DeLuca; A J Hamstra
Journal:  N Engl J Med       Date:  1978-11-02       Impact factor: 91.245

4.  Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.

Authors:  Y Seino; T Shimotsuji; T Ishii; M Ishida; C Ikehara; K Yamaoka; H Yabuuchi; S Dokoh
Journal:  Arch Dis Child       Date:  1980-01       Impact factor: 3.791

5.  Fetal plasma prolactin levels.

Authors:  A J Winters; C Colston; P C MacDonald; J C Porter
Journal:  J Clin Endocrinol Metab       Date:  1975-09       Impact factor: 5.958

6.  Parathyroid function in infants of diabetic mothers.

Authors:  R C Tsang; I Chen; M A Friedman; M Gigger; J Steichen; H Koffler; L Fenton; D Brown; A Pramanik; W Keenan; R Strub; T Joyce
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

7.  Competitive protein binding assay for 1,25-dihydroxy-vitamin D in human plasma.

Authors:  S Dokoh; R Morita; M Fukunaga; I Yamamoto; K Torizuka
Journal:  Endocrinol Jpn       Date:  1978-10

8.  Radioreceptor assay for 1 alpha,25-dihydroxyvitamin D3.

Authors:  P F Brumbaugh; D H Haussler; R Bressler; M R Haussler
Journal:  Science       Date:  1974-03-15       Impact factor: 47.728

  8 in total
  11 in total

1.  Serum vitamin D metabolites are not related to growth rate, bone mineral content, or serum alkaline phosphatase in male puberty.

Authors:  S Krabbe; C Christiansen; L Hummer
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

2.  Biochemical characterization of 1,25(OH)2D3 receptors in chick embryonal duodenal cytosol.

Authors:  Y Seino; K Yamaoka; M Ishida; H Yabuuchi; M Ichikawa; H Ishige; H Yoshino; L V Avioli
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

3.  Plasma active vitamin D concentration in low birthweight infants with rickets and its response to vitamin D treatment.

Authors:  Y Seino; T Ishii; T Shimotsuji; M Ishida; H Yabuuchi
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

4.  Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children.

Authors:  P H Stern; A B Taylor; N H Bell; S Epstein
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

5.  Differential diagnosis of hypoparathyroid disorders during childhood.

Authors:  M Ishida; Y Seino; T Simotsuji; T Ishii; K Yamaoka; T Harada; H yabuuchi; K Nishimura
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

6.  Calcium homeostasis in premature infants and treatment of early hypocalcaemia by 1,25-dihydroxycholecalciferol.

Authors:  C Y Lin; M Ishida
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

7.  Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females.

Authors:  S Nakamura; S Morimoto; S Takamoto; T Onishi; K Fukuo; E Koh; S Kitano; Y Miyashita; O Yasuda; M Tamatani
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

8.  1,25(OH)2D and 24,25(OH)2D production in the developing kidney.

Authors:  M Ishida; M Shima; Y Seino
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

9.  Increased circulating levels of gamma-carboxyglutamic acid-containing protein and decreased bone mass in children on anticonvulsant therapy.

Authors:  N Takeshita; Y Seino; H Ishida; Y Seino; H Tanaka; C Tsutsumi; K Ogata; K Kiyohara; H Kato; M Nozawa
Journal:  Calcif Tissue Int       Date:  1989-02       Impact factor: 4.333

10.  Serum calcium regulating hormones in the perinatal period.

Authors:  Y Seino; M Ishida; K Yamaoka; T Ishii; T Hiejima; C Ikehara; Y Tanaka; S Matsuda; T Shimotsuji; H Yabuuchi; S Morimoto; T Onishi
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.